Literature DB >> 836955

Effects of ascorbic acid on glucose-6-phosphate dehydrogenase-deficient erythrocytes: studies in an animal model.

T Udomratn, M H Steinberg, G D Campbell, F J Oelshlegel.   

Abstract

There is little information available concerning the possible effects of ascorbic acid on glucose-6-phosphate dehydrogenase (G-6-PD) -deficient erythrocytes. We therefore studied the survival of G-6-PD-deficient cells, incubated with ascorbic acid, in rats with partial reticuloendothelial and complement blockade. Animals were pretreated with ethyl palmitate and cobra venom factor. They were then transfused with 51Cr-labeled erythrocytes which had been incubated in the presence or absence of ascorbic acid. G-6-PD-deficient cells, incubated with ascorbic acid, had impaired survival when compared to that of controls. G-6-PD-deficient cells, in the absence of ascorbic acid, had survival times equal to those of normal control erythrocytes. At the concentrations used, ascorbic acid did not appear to alter the survival of normal cells. Ascorbic acid causes premature loss of G-6-PD-deficient human erythrocytes in this rat model. On the basis of previous clinical and experimental observations, as well as this study, caution should be used when administering ascorbic acid in large doses to individuals who might be G-6-PD deficient.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836955

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency.

Authors:  D C Rees; H Kelsey; J D Richards
Journal:  BMJ       Date:  1993-03-27

2.  Effect of ascorbic acid on copper-induced oxidative changes in erythrocytes of individuals with a glucose-6-phosphate dehydrogenase deficiency.

Authors:  E J Calabrese; G S Moore; M S McCarthy
Journal:  Bull Environ Contam Toxicol       Date:  1983-03       Impact factor: 2.151

3.  Ascorbic acid enhances the occurrence of copper-induced methemoglobin formation in normal human erythrocytes in vitro.

Authors:  E J Calabrese; G S Moore; M S McCarthy
Journal:  Bull Environ Contam Toxicol       Date:  1982-12       Impact factor: 2.151

Review 4.  Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks.

Authors:  R O Francis; J S Jhang; H P Pham; E A Hod; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2013-07-02       Impact factor: 2.144

Review 5.  Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.

Authors:  Ilan Youngster; Lidia Arcavi; Renata Schechmaster; Yulia Akayzen; Hen Popliski; Janna Shimonov; Svetlana Beig; Matitiahu Berkovitch
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.228

6.  Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins.

Authors:  Stephanie Seneff; Nancy L Swanson; Gerald Koenig; Chen Li
Journal:  Dis Markers       Date:  2016-09-28       Impact factor: 3.434

7.  Effect of High-Dose Vitamin C Infusion in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient.

Authors:  Joseph Quinn; Bryan Gerber; Ryan Fouche; Katharine Kenyon; Zachary Blom; Purushothaman Muthukanagaraj
Journal:  Case Rep Med       Date:  2017-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.